← Back to Drug List

ICATIBANT INJ,SOLN

Clinical Criteria Summary

Exclusion Criteria

  • Concomitant use with another acute therapy agent for HAE (e.g., ecallantide or sebetralstat)

Inclusion Criteria

  • Restricted to VA / VA Community Care allergy/immunology, dermatology, or emergency medicine providers or locally designated expert
  • Suspected bradykinin-mediated angioedema

Source Documents